Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01684215 |
|---|---|
| Brief Title: | A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer |
| First Submitted : | September 10, 2012 |
| First Submitted that Met QC Criteria : | September 10, 2012 |
| First Posted : | September 12, 2012 (Estimate) |
| Results First Submitted : | November 9, 2016 |
| Results First Submitted that Met QC Criteria : | March 21, 2017 |
| Results First Posted : | May 2, 2017 |
| Last Update Submitted that Met QC Criteria : | October 28, 2020 |
| Last Update Posted : | November 23, 2020 |